Incyte Corp. diskutieren
Incyte Corp.
WKN: 896133 / Symbol: INCY / Name: Incyte / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
81,32 €
-1,78 %
Incyte Corporation (NASDAQ: INCY) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $89.00 price target on the stock, up previously from $67.00.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at Bank of America Corporation from $90.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at Stifel Nicolaus from $110.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $125.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at Piper Sandler from $82.00 to $102.00. They now have an "overweight" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) was given a new $121.00 price target on by analysts at Mizuho. They now have an "outperform" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $121.00 price target on the stock, up previously from $90.00.
Ratings data for INCY provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Amazon.com Inc. diskutieren